This indicates that HIF‐1α was upregulated in MDS patients and connected with factors related to poor prognosis, such as conversion to AML, increasing percentage of initial cells, increasing lactate dehydrogenase level, and short survival time. The gene discussed is HIF1A; the disease is acute myeloid leukemia.